💡 Key Takeaways
- June is officially recognized as Migraine Awareness Month.
- Migraines are a debilitating neurological condition and an invisible illness that drastically disrupts work, school, and social lives.
- A new clinical trial for a potential new medication for treating migraine is being conducted at research sites located in New South Wales, Queensland, Victoria, and Adelaide.
- Eligible participants must be between 18 and 65 years old, have been living with migraine for more than 1 year, and usually have at least 2 but not more than about 8 moderate or severe migraine headaches in a month.
- Participation in the study will be up to 3 months with 3 clinic visits required and participants will receive study-related care at no cost and be reimbursed for travel and time.
- This study has been approved by the Bellberry Human Research Ethics Committee.
Affecting 5 million people nationwide, migraines are a debilitating neurological condition characterised by intense, throbbing pain, nausea, vomiting, and sensitivity to light and sound. Some sufferers also experience visual auras that warn of an upcoming attack. For those affected, migraines drastically disrupt work, school, and social lives.
I feel very comfortable writing about this topic because I’ve been a migraine sufferer since I was thirteen. Living with migraines is scary and unpredictable, especially when they aren’t under control. Perhaps the hardest part is that it’s an invisible illness – no one can see your pain or struggle. More than a few times, I’ve had to slip away quietly from events to retreat to a dark room.
As I’ve gotten older, and with the help of medication, my migraines are finally under control – a reprieve I never take for granted. It took years of learning, but a major change in my diet and lifestyle allows me to live a virtually migraine-free existence right now. Because I know firsthand how challenging this journey is, I’m thrilled to share the news about a groundbreaking new study coming very soon.
Are you eligible for a new migraine study?
A new study is being conducted at research sites located in New South Wales, Queensland, Victoria and Adelaide.
If you are living with migraine and answer ‘yes’ to the following questions, you may be eligible to participate in a clinical trial for a potential new medication for treating migraine.
- Are you between 18 and 65 years old?
- Have you been living with migraine for more than 1 year?
- Were you under 50 years old when your migraine headaches started?
- Do you usually feel nauseous or sick in your stomach or sensitive to light or noise when you have a migraine attack?
- Do you usually have at least 2 but not more than about 8 moderate or severe migraine headaches in a month?
The study is being conducted at research sites located in New South Wales in Wollongong, Brookvale, Waitara, North Sydney and Darlinghurst.
You will receive study-related care and assessments at no cost, you will be reimbursed for your travel and time. Your participation in the study will be up to 3 months, with 3 clinic visits required.
To see if you qualify, please email Zave and they will contact you to discuss the study further.
This study has been approved by Bellberry Human Research Ethics Committee.
